Navigation Links
'Awake cardiac surgery' performed at Madurai hospital

A rare "awake cardiac surgery", in which the patient remains awake throughout the procedure, has been performed by a private hospital here on a 53-year-old man. //

A two graft coronary artery bypass was performed on Nagarajan, a bus conductor, at the Meenakshi Mission Hospital and Research Centre on Monday, the hospital authorities claimed today.

This was the first time the 'awake cardiac surgery' was done in Tamil Nadu, they said.

Dr A R Raguram, Chief Cardiac Surgeon at the MMHRC, told reporters that Nagarajan of Dindigul was admitted with severe chest pain and was advised bypass surgery.

During the surgery, the patient was awake with a continually beating heart as he was not given general anaesthesia. He was talking and joking while his chest was opened and the two grafts were sewen, Raguram said.

According to Dr.S.Kumar, Chief Cardiac Anesthesiologist of MMHRC, this was made possible because the patient's pain sensation was completely arrested in the operation site by selectively blocking nerves using a strategically placed catheter in the back and continuously injecting drugs. This is called cervical epidural anaesthesia.

One of the main advantages of the procedure is the absence of an irritating tube in the throat (used for anaesthesia) for the patient.

According to Kumar, another advantage is that the blood pressure variation during the surgery is reduced to minimum and patient is spared the discomfort of a tube in the nose and throat. The intensive care unit stay is minimized.

However, he cautioned that this procedure was not meant for everybody as it needs anesthetists with high degree of technical competence, vigilant care during surgery and a patient with cooperative attitude.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Thyroid hormone treatment hastens recovery after cardiac surgery
2. Gene HPA-2 Met linked to cardiac arrest
3. Supplement helps cardiac surgery
4. Latest device for cardiac revival under test
5. Bone marrow stem cells may help repair cardiac tissues
6. Antibiotics not to reduce rate of cardiac diseases
7. Traditional risk factors are more harmful than newer factors of cardiac disease
8. Ordinary drugs can interfere with death from cardiac problems
9. Teens with diabetes may be already having cardiac problems
10. MRI can predict risk of cardiac arrhythmia by identification of scar tissue
11. Want to relieve non cardiac chest pain: try hypnosis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Awake cardiac surgery performed Madurai hospital

(Date:9/2/2015)... ... September 02, 2015 , ... Amada Senior Care, premier provider ... Kansas – its Johnson County location. Amada franchise partners Mike and Mell ... registered nurse background and spent over 20 years in medical device sales while Mell ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... Hand Free Pocket Cop, a safety invention that protects people from crime and ... $31 billion," says Scott Cooper, CEO and Creative Director of World Patent Marketing. ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... for the upper extremity surgical market, announced today that more than 600 successful ... releases in the hand. Plus, nearly 70 of these procedures have been ...
(Date:9/2/2015)... ... September 02, 2015 , ... Based ... GROUP is internationally known as an industry leader specializing in surplus used medical ... selling more than 100,000 pieces of medical equipment every year. Erik Tivin, Chairman ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... document imaging, content, records and case management solutions and services to both government ... its Image Re-sizing and Image Clean-up utility for IBM’s Datacap document capture platform. ...
Breaking Medicine News(10 mins):Health News:Amada Senior Care Expands to Greater Kansas City 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 4Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 5Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 6Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 7Health News:Trigger Tome Surpasses 600 Successful Patient Procedures 2Health News:Over 1800 Lots of Surplus Used Medical Equipment 2Health News:Over 1800 Lots of Surplus Used Medical Equipment 3Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 3
... the FDA and pharmaceutical manufacturers contemplate the development ... extended release opioids, thousands of clinicians who treat ... resource that supports the safe and effective use ... ( www.emergingsolutionsinpain.com ) is a multi-award winning, ...
... do more to promote awareness, study says , , FRIDAY, Feb. ... by name or role -- the doctors assigned to their ... , "The majority of hospitalized patients we looked at were ... said study author Dr. Vineet Arora, associate program director at ...
... MA A new national survey conducted by the Harvard ... finds that the vast majority (93%) of Americans have heard ... Among those who are aware of the recall, about six ... precautions to reduce their risk of getting sick from contaminated ...
... bid to help underserved children, the Children,s Health Fund ... Radiology System, donated by Siemens. Bidding for the ... quarter million dollars in the first ten days. ... at: , http://inr.mediaseed.tv/oneClip_C/?feed=EEHPWrm_uGEQOCdpx2JU_mPv2Er3Cvod The winning bid was ...
... Tests in mice were successful, and human trials are ... -- A new herbal formula based in ancient Chinese ... peanuts and other foods, researchers from New York City,s ... are potentially life-threatening for children and adults. Food allergies ...
... SALT LAKE CITY, Feb. 13 Dynatronics Corporation (Nasdaq: ... quarter and six months ended December 31, 2008. Operating results ... December 31, 2007. Pre-tax profit for the quarter ended December ... of $521,656 for the second quarter of the prior fiscal ...
Cached Medicine News:Health News:Opioid Safety and Efficacy Web Resource for Clinicians Supports Education and Practice Needs 2Health News:Opioid Safety and Efficacy Web Resource for Clinicians Supports Education and Practice Needs 3Health News:Many Hospital Patients Can't ID Their Doctors 2Health News:Many Hospital Patients Can't ID Their Doctors 3Health News:Following peanut product recall, six in ten Americans taking steps to reduce risk of sickness 2Health News:Following peanut product recall, six in ten Americans taking steps to reduce risk of sickness 3Health News:Herbal Remedy Could Halt Peanut Allergy 2Health News:Herbal Remedy Could Halt Peanut Allergy 3Health News:Dynatronics Reports Profitable Second Quarter - Signaling Significant Improvement Over Prior Year Results 2Health News:Dynatronics Reports Profitable Second Quarter - Signaling Significant Improvement Over Prior Year Results 3Health News:Dynatronics Reports Profitable Second Quarter - Signaling Significant Improvement Over Prior Year Results 4
(Date:9/1/2015)... 2015  Amgen (NASDAQ: AMGN ) today ... areas of Alzheimer,s disease and migraine. The collaboration ... teaming up with Novartis on a differentiated and ... predisposed individuals at risk of developing Alzheimer,s disease. ... commercialization of its migraine programs in the U.S., ...
(Date:9/1/2015)... , Sept. 1, 2015 Nevro Corp. (NYSE: ... is providing innovative evidence-based solutions for the treatment of ... its preliminary response to the Patent Trial and Appeals ... inter partes review (IPR), filed by a unit of ... in U.S. Patent No. 8,359,102 (the ,102 patent). The ,102 ...
(Date:9/1/2015)... THOUSAND OAKS, Calif. and ... (NASDAQ: AMGN ) and UCB (Euronext Brussels: ... trial (STudy evaluating effect of RomosozUmab Compared with ... risk for fracture pReviously treated with bisphosphonatE therapy). ... a statistically significant difference in favor of romosozumab ...
Breaking Medicine Technology:Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 2Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 3Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 4Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 5Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 6Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 7Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 8Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 9Nevro Announces Submission of Preliminary Response to the Patent Trial and Appeals Board 2Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 2Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 3Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 4Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 5Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 6Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 7Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 8Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 9
... Exp Expandable Tip System A ... System allows you to perform multi-sample transfers between ... pull of a knob, tip spacing can be ... microcentrifuge tubes) or 96 well plates. Ergonomic ...
... Expandable Tip System A lower cost alternative ... to perform multi-sample transfers between two different vessel ... knob, tip spacing can be quickly and easily ... 96 well plates. Ergonomic Design for Unparalleled ...
... Expandable Tip System A lower cost alternative ... to perform multi-sample transfers between two different vessel ... knob, tip spacing can be quickly and easily ... 96 well plates. Ergonomic Design for Unparalleled ...
... Exp Expandable Tip System A lower ... allows you to perform multi-sample transfers between two ... of a knob, tip spacing can be quickly ... tubes) or 96 well plates. Ergonomic Design ...
Medicine Products: